Management Tracks: Zai taps Sandler as cancer head, plus moves at FibroGen, Arena, Samumed, Avita, Mersana, Frequency, Matinas, NeuBase, Allena and RA 

Zai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688) hired Alan Sandler as president, head of global development, oncology, a newly created position. Sandler was SVP and global head of product development oncology at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). 

FibroGen Inc. (NASDAQ:FGEN) hired Mark Eisner as CMO, effective Dec. 21. Eisner was SVP and global head of product development immunology, infectious disease and ophthalmology at Roche, and succeeds K. Peony Yu, who is retiring. Yu will remain with FibroGen as an executive adviser to the CEO through March 15, 2021. ...